Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06361511 · ClinicalTrials.gov registry record · NA

The Foods & Oil to Repair, Correct and Enhance Strength (FORCES) Study

A NA study of Sarcopenia, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT06361511: Recruiting NA study of Sarcopenia, sponsored by Ohio State University.

NCT06361511 is a NA study of Sarcopenia that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 66 participants, below the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06361511, a NA study of Sarcopenia, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The proposed research is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in muscle strength, volume, fatigue resistance, and mobility in older adults after daily consumption of 12g of linoleic acid-rich oil.

Primary Outcome

To determine the impact of high linoleic safflower oil on isokinetic leg extensor muscle strength through isokinetic dynamometer

Conditions Studied

Interventions

  • OTHER High Linoleic Acid Foods
  • OTHER High Oleic Acid Foods

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-05-01
Est. Completion 2030-05-01
Phase NA
Ohio State University

552 total trials

What NCT06361511 shows while recruiting

NCT06361511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target (16% lower).

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which High Linoleic Acid Foods is the first listed.

NCT06361511 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06361511 about?

NCT06361511 is a clinical study titled "The Foods & Oil to Repair, Correct and Enhance Strength (FORCES) Study". The proposed research is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in muscle strength, volume, fatigue resistance, and mobility in older adults after daily consumption of 12g of linoleic acid-rich oil.

What is the current status of trial NCT06361511?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-05-01. Estimated completion is 2030-05-01.

What conditions does trial NCT06361511 study?

This clinical trial studies the following conditions: Sarcopenia.

What interventions are being tested in trial NCT06361511?

The interventions under investigation include: High Linoleic Acid Foods (OTHER), High Oleic Acid Foods (OTHER).

Who is sponsoring clinical trial NCT06361511?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06361511 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06361511's enrollment target sits among peer trials

66 19th of 41 higher than 23 of 41 other Sarcopenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06361511, the US trial registry maintained by the National Library of Medicine. NCT06361511 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.